Voice from the floor - inflammation in the future

Microphone for interview

Prof  Feyza Aricioglu, Professor of Pharmacology, Marmara University, Turkey, spoke to our correspondent at EPA 2017 about new areas of research and challenges in the field of psychiatry. She emphasized that the whole field of psychiatry is a dynamic area in terms of pharmacology and new treatment strategies. The more we learn about neurobiology, the more we can come up with better treatment strategies. One of the hot topics at the moment is inflammation. An increase in pro-inflammatory cytokines seems to be an overlapping area for schizophrenia, depression and anxiety. Inhibitors of pro-inflammatory cytokines may represent a new way to approach these diseases.

The whole field of psychiatry is a dynamic area in terms of pharmacology and new treatment strategies

She referred to a review article from 2013, which concluded that many diseases have an inflammatory basis, such as rheumatoid arthritis, diabetes, and others. Many of those patients - up to 40% - also suffer from depression. So there may be close relationship between inflammation and depression.

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country